Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...
Critical care (London, England), 2021-12, Vol.25 (1), p.440-15, Article 440
Ort / Verlag
England: BioMed Central Ltd
Erscheinungsjahr
2021
Link zum Volltext
Quelle
MEDLINE
Beschreibungen/Notizen
Oxygen (O
) toxicity remains a concern, particularly to the lung. This is mainly related to excessive production of reactive oxygen species (ROS). Supplemental O
, i.e. inspiratory O
concentrations (F
O
) > 0.21 may cause hyperoxaemia (i.e. arterial (a) PO
> 100 mmHg) and, subsequently, hyperoxia (increased tissue O
concentration), thereby enhancing ROS formation. Here, we review the pathophysiology of O
toxicity and the potential harms of supplemental O
in various ICU conditions. The current evidence base suggests that PaO
> 300 mmHg (40 kPa) should be avoided, but it remains uncertain whether there is an "optimal level" which may vary for given clinical conditions. Since even moderately supra-physiological PaO
may be associated with deleterious side effects, it seems advisable at present to titrate O
to maintain PaO
within the normal range, avoiding both hypoxaemia and excess hyperoxaemia.